Regulatoriskt pressmeddelande

Swedencare AB (publ) Press release from the Annual General Meeting 2025

At Swedencares Annual General Meeting, on April 25, 2025, the following decisions were made:

Adoption of the income statement and balance sheet
The Annual General Meeting decided on the adoption of the income statement and balance sheet as well as consolidated income statement and consolidated balance sheet for the financial year 2024.

Dispositions regarding the Company´s profit
The Annual General Meeting decided on a dividend of SEK 0.25 per share, corresponding to a total of 39,960,240 SEK. The recording date for the right to receive dividends is decided to be April 28^th, 2025. Dividends are expected to be paid through Euroclear Sweden AB on May 2^rd, 2025.

Discharge from liability towards the Company for the Board members and the CEO
The Annual General Meeting decided to grant discharge from liability towards the Company to the Board members and the CEO for the year 2024.

Determination of fees to the Board and Auditor
The Annual General Meeting decided on Board fees of a total of 1,700,000 SEK to be distributed with 700,000 SEK to the Chairman and 250,000 SEK each to other members elected by the Annual General Meeting, except representatives for Symrise Group. For committee work, to the members appointed by the board: 125,000 SEK to the chairman of the audit committee. No compensation is paid to the chairman of the remuneration committee and the other members of the committee.

Auditor fee according to approved bill.

Election of Board members, Chairman of the Board, and auditor
The Annual General Meeting decided on re-electing the board members Håkan Svanberg, Johan Bergdahl, Thomas Eklund, Sara Brandt, Ulrika Valassi and Jean-Yves Pariot. Also new electing Isabelle Guiller. The Annual General Meeting decided to elect Håkan Svanberg as Chairman of the Board.

The Annual General Meeting decided to re-elect Deloitte AB with Maria Ekelund as principal auditor for the period until the end of the Annual General Meeting of 2026.

Principles for the appointment of a nomination committee
The Annual General Meeting decided to adopt principles for the appointment of a nomination committee meaning mainly that the three (3) largest shareholders of the company per September 30^thhave the right to appoint a member to the nomination committee.

Authorization for the Board of Directors to resolve on the issue of shares
The Annual General Meeting decided to authorize the Board of Directors to, on one or more occasions during the period until the next Annual General Meeting, decide to increase the company's share capital by a maximum of 17 760 106 shares through a new issue of shares. The Board shall be able to decide on the issue of shares with deviation from the shareholders' preferential rights and/or with a provision on non-cash, set-off or otherwise with conditions in accordance with Chapter 2, § 5, second paragraph 1-3 and 5 of the Companies Act.

Resolution on Employee Stock Option Program to senior executives and certain key employees based in the United States
The annual general meeting decided, in accordance with the proposal from the board, to introduce an employee stock option program 2025.

About Swedencare

Swedencare is listed on the NASDAQ First North Growth Market and also trades on the OTCQX® Best Market. We develop, produce, and sell premium products in the global and rapidly growing pet healthcare market, focusing on cats, dogs, and horses. Our extensive product portfolio includes strong brands such as NaturVet®, Innovet, Pet MD®, Rx Vitamins®, nutravet®, Rileys®, and ProDen PlaqueOff®, the original solution for good oral health.

With headquarters in Malmö, our products are sold in approximately 70 countries through veterinarians, pet stores, and online. Our extensive distribution network consists of subsidiaries in nine countries, along with an international network of retailers. Swedencare has experienced strong growth for several years while maintaining high profitability.